Cortical gyrification and its relationships with molecular measures and cognition in children with the FMR1 premutation

Abstract

Neurobiological basis for cognitive development and psychiatric conditions remains unexplored in children with the FMR1 premutation (PM). Knock-in mouse models of PM revealed defects in embryonic cortical development that may affect cortical folding. Cortical-folding complexity quantified using local gyrification index (LGI) was examined in 61 children (age 8–12 years, 19/14 male/female PM carriers, 15/13 male/female controls). Whole-brain vertex-wise analysis of LGI was performed for group comparisons and correlations with IQ. Individuals with aberrant gyrification in 68 cortical areas were identified using Z-scores of LGI (hyper: Z ≥ 2.58, hypo: Z ≤ − 2.58). Significant group-by-sex-by-age interaction in LGI was detected in right inferior temporal and fusiform cortices, which correlated negatively with CGG repeat length in the PM carriers. Sixteen PM boys (hyper/hypo: 7/9) and 10 PM girls (hyper/hypo: 2/5, 3 both) displayed aberrant LGI in 1–17 regions/person while 2 control boys (hyper/hypo: 0/2) and 2 control girls (hyper/hypo: 1/1) met the same criteria in only 1 region/person. LGI in the precuneus and cingulate cortices correlated positively with IQ scores in PM and control boys while negatively in PM girls and no significant correlation in control girls. These findings reveal aberrant gyrification, which may underlie cognitive performance in children with the PM.

Introduction

The fragile X premutation (PM) is characterized by a 55–200 CGG repeat expansion in the 5′ untranslated region of the fragile X mental retardation 1 (FMR1) gene located on the X-chromosome1. The mutation is associated with a spectrum of clinical conditions affecting PM carriers across the lifespan. Two associated disorders have been identified, namely: fragile X-associated tremor/ataxia syndrome (FXTAS) that occurs in 45% of male PM carriers and 16% of female PM carriers after age 502,3 and fragile X-associated primary ovarian insufficiency (FXPOI) that affects 16–20% female PM carriers before age 40. Fragile X-associated neuropsychiatric disorders (FXAND) is a newly proposed group of disorders that may affect a subset of children and adults with the PM4. Although the prevalence of developmental delay is not increased in the PM population5, a national parent survey of 1276 families of children with the fragile X syndrome indicates that children with the PM have increased risks to be diagnosed or treated for anxiety, attention-deficits/hyperactivity disorder (ADHD), and social impairment compared with age and family-income matched controls6. Both probands who are clinically referred and nonprobands who are identified as a result of family investigation have been shown to present a higher rate of involvement compared with non-carrier controls or the general population6,7,8,9. In adult PM carriers, anxiety, depression, ADHD, obsessive compulsive disorder (OCD), and substance abuse are the most common types of neuropsychiatric conditions8,9,10,11,12,13,14. Sensory difficulties can occur as early as in infants with the PM, who displayed hypersensitivities that have a potential to be clinically relevant later in life15,16. Cognitively, a higher threshold level in motion contrast detection compared with typically developing infants has been reported15,16,17. Additionally, adult PM carriers without FXTAS showed longer manual movement and reaction times18 as well as subtle impairment in executive function and declarative learning and memory performance19,20. In a non-clinical referred sample of 64 young PM carriers who were unaffected by FXTAS and without children with fragile X full mutation, higher rates of autism-related symptoms in males and high rates of obsessive–compulsive symptoms in female compared with age- and sex-matched non-carrier controls have been reported10. FMRP deficiency may also be associated with higher rates of anxiety disorders since the percentage is higher in carriers with intellectual disability (ID) (81.8%) compared to carriers with normal IQ (62.5%)8. Significant correlations between elevated FMR1 mRNA level and obsessive–compulsive symptoms and psychoticism have also been reported in adult PM carriers, supporting the role of the RNA-toxicity in neuropsychiatric conditions. Other potential mechanisms for neuropsychiatric vulnerabilities include rare copy number variation detected in PM children with behavior and/or neuropsychiatric problems21, mitochondrial dysfunction22,23, chronic DNA damage repair24, and the presence of FMRPolyG, the toxic protein product of the repeat-associated non-AUG (RAN) translation of the expanded-CGG containing mRNA25.

Despite the accumulating evidence of the elevated risk of developmental problems, neurobiological substrates of cognitive development and neuropsychiatric conditions have not been investigated in children with the premutation. The knock-in mouse models of the PM have provided clues suggesting that altered neocortical development may occur as early as during late embryogenesis. A study of embryonic neocortical development in PM mice26 detected FMRP expressions in both radial glial cells in the ventricular zone and neural precursor cells in the subventricular zone albeit the overall FMRP expression in the neocortex was slightly reduced compared with the wild-type. The lower FMRP expression may lead to delayed differentiation of neocortex neurons and impaired neuronal migration observed in the embryonic PM neocortex26. In addition, the level of expanded CGG-containing FMR1 mRNA is elevated in PM carriers (i.e., the RNA toxicity), which may sequester proteins important for neurodevelopment27,28,29. Demonstrated in a recent study of PM mice, reducing FMR1 mRNA levels using small interfering RNA (siRNA) normalized the expression of 29 proteins including RNA-binding proteins and mitochondrial proteins, and rescued alterations in dendritic morphology in cultured hippocampal neurons30. These findings support the pathogenic role of the RNA toxicity affecting brain structure and function. Although it cannot be directly observed in lissencephalic species such as mice, cortical folding or gyrification may be affected in PM carriers. Formed mainly during the 4th fetal month to first postnatal year in humans, gyrification is a complex process under the control of tightly regulated gene expression in both temporal and spatial dimensions31. Perturbations of gene expression during this period are found to affect neuronal proliferation, migration, and differentiation, which would ultimately result in altered gyrification32.

To understand neurobiological bases for cognitive development and neuropsychiatric conditions in PM carriers, we examined cortical folding in children with the PM and its relationships with FMR1 molecular measurements and cognitive functioning. Given the variability found in the phenotype of children with the PM4, we explored gyrification analyses at both group and individual levels to account for potential spatial and directional (i.e., hyper- or hypo-gyrification) variations in gyrification. Gyrification was quantified using local gyrification index (LGI)33, the ratio of total surface area (both hidden within the sulci and exposed on the outer surface of the brain) and exposed surface area. The comparison measurements were cortical thickness (CT) and surface area (SA), which are likely to also be affected by the PM.

Results

We examined brain scans from 61 children–33 PM carriers (19 boys, 14 girls) and 28 age-matched controls (15 boys, 13 girls) aged 8–12 years (Table 1). Visual inspection of the MRI scans did not detect any scans with excessive motion artifacts that would affect LGI-quantifications. To further assure image quality, we obtained Euler number generated by the Freesurfer software package34, which summarizes topological complexity of the cerebral cortex but has been shown to correlate with manual identification of “unusable” scans35, as well as nine LONI Quality Control (QC) metrics that were unlikely to be affected by topological complexity36. The nine LONI metrics comprised (1) mean slice intensity (MSI), (2) signal to noise ratio (SNR), (3) signal variance-to-noise variance ratio (SVNR), (4) contrast-to-noise ratio (CNR), (5) contrast of variance-to-noise ratio (CVNR), (6) brain tissue contrast-to-tissue intensity variation (TCTV), (7) full-width-at-half-maximum (FWHM), (8) center of mass (CoM), and (9) coefficient of variation (COV). To determine the cutoffs for “unusable” scans, we utilized two scans acquired from a 7-year-old male control and a 13-year-old PM male, who were outside of the age range and showed excessive motion artifacts. The Euler numbers were − 330 and − 468, respectively (Supplementary Fig. S1a,b). In the current dataset, only the Euler number of − 334 (Supplementary Fig. S1c) overlapped with those of the two “unusable” scans. Of the nine QC metrics from LONI, only SNR and COV were able to separate the two “unusable” scans from the remaining scans with no overlapping (SNR: z = − 3.2 and − 2.5, COV: z = − 2.8 and − 2.5) while the other seven metrics were nowhere near useful (i.e., z-scores close to mean or in the wrong direction). However, the scan with the Euler number of − 334 had z-scores of SNR and COV at − 0.43 and − 0.48, respectively. To avoid excluding scans because of topological complexity we decided to include this scan. To take into account of the potential effect of movement on the results, we reported results with and without using the Euler number as a covariate for analyzing CT and SA.

Table 1 Characteristics of research participants: mean (SD).

Among the 33 PM carriers, nine boys and two girls were probands while the remaining PM carriers were nonprobands (Supplementary Table S1). WISC-IV scores were obtained from 56 participants, which were significantly lower in male PM carriers than male controls (p < 0.001–0.010) but showed no differences between the female PM carriers and controls (p > 0.05) (Table 1). The medical history revealed 80.0% PM carriers (17/19 boys and 7/11 girls) who were diagnosed with anxiety disorder, and 50% (12/19 boys and 3/11 girls) who showed ADHD symptoms. All PM carriers with ADHD were comorbid with anxiety disorder except for one boy. However, the rate of anxiety, ADHD, and FSIQ < 80 were not preferentially higher in the probands compared with the nonprobands (Supplementary Table S2).

Group-by-sex-by-age interaction in LGI and CT

In whole brain vertex-wise analysis of LGI, three levels of cluster-forming threshold (CFT) (0.05, 0.01, and 0.005) were tested and reported. Using CFT of p = 0.010 revealed one cluster in the supramarginal cortex extending to the inferior parietal cortex (LGI1) displaying significant group-by-age interaction (p = 0.024) and another cluster in the right inferior temporal cortex extending to the fusiform (LGI2) showing significant group-by-sex-by-age interaction (p = 0.019) (Table 2, Fig. 1a,b). The analysis of the comparison variable, CT, detected a cluster in the right lateral orbitofrontal cortex extending to the frontal pole and medial orbitofrontal cortices (CT1) showing significant group effect (p = 0.006) (Fig. 1c). In addition, a cluster in the right lateral occipital cortex (CT2) showed significant group-by-sex-by-age interaction (p = 0.002) (Table 2, Fig. 1d). Two of the clusters, LGI2 and CT2, also survived the more stringent CFT threshold of p = 0.005 but with a smaller cluster size compared with CFT of p = 0.010 (Table 2). In contrast, no clusters showed any significant effect in SA. Using CFT of p = 0.050, two additional LGI clusters showed group-by-sex-by-age and group-by-age interactions, respectively, and one cluster of SA showed a group-by-age interaction (Table 2).

Table 2 Cortical regions showing significant effect in group analysis using 10 mm smooth kernals for CT and SA.
Figure 1
figure1

Vertex-wise group comparisons of LGI and CT. (a) A cluster peaked at the left supramarginal gyrus (SMG) showing group-by-age intereaction in LGI. (b) A cluster peaked at the right inferior temporal cortex (IT) showing group-by-sex-by-age interaction in LGI. (c) A cluster peaked at the right lateral orbitofrontal cortex (LOF) showing group effect in CT. (d) A cluster peaked at the right lateral occipital cortex (LO) showing group-by-sex-by-age interaction in CT. All clusters were formed using the CFT of p = 0.010. Cluster-wise p values are shown in the graph.

We also tested the effect of Euler on cortical measures and repeated the CT and SA analyses after adding the Euler number as a covariate. Three LGI clusters survived the CFT of 0.01, showing negative correlation with the Euler number centered in left precentral cortex, right inferior parietal cortex, and right rostral middle frontal cortex (Table 2, Supplementary Fig. S2a,b). In contrast to no Euler effect on CT even at CFT of 0.05, an SA cluster passed CFT of 0.01 centered at left superior frontal cortex (Table 2, Supplementary Fig. S2c). All of the three LGI clusters and the SA cluster also survived the more stringent CFT of 0.005. After controlling for the Euler number, only two CT clusters passed CFT of 0.05, showing group effect centered at right lateral orbitofrontal cortex and group-b-age interaction centered at right superior parietal cortex (Table 2). No significant clusters of SA were found at any CFT level. The above analyses were repeated after excluding the 4 scans acquired using a 32-channel head coil from one male control, one female PM carrier, and two male PM carriers. The same clusters with similar sizes and levels of significance were detected.

Post-hoc analyses were performed to study the associations between the average LGI of the significant clusters and CGG repeat length and FMR1 mRNA level, using multiple linear regression. Age and total cranial volume (TCV) were included as covariates. For female PM carriers, CGG repeat size of the premutation allele and the activation ratio (AR), indicating the percentage of cells carrying the normal allele on the active X chromosome, were included in the analysis. The analyses revealed a significant negative association between cluster LGI2 with CGG repeat length in male PM carriers (β = − 0.0014 ± 0.0005, p = 0.010) (Supplementary Fig. S3a). Significant correlations between LGI2 and CGG repeat length (β = − 0.0019 ± 0.0004, p = 0.001) and the activation ratio (β = − 0.29 ± 0.064, p = 0.002) were also demonstrated in female PM carriers after excluding a girl showing an outlier effect (Supplementary Fig. S3b,c). LGI of this cluster exhibited a negative correlation with CT (r = − 0.27, p = 0.038) and a positive correlation with SA (r = 0.32, p = 0.013) combining all four groups without the adjustment for age and TCV.

Majority (78.8%) of the PM carriers showed aberrant gyrification

Individuals with Z-scores above 2.58 and below − 2.58 were considered as having hyper- and hypo-gyrification, respectively. The analysis of average LGI of 68 cortical regions demonstrated that 78.8% PM carriers (16/19 boys, 10/14 girls) showed 1–17 regions with hyper- or hypo-gyrification in contrast to 14.3% controls (2/15 boys, 2/13 girls) showing one such region per person. Regions with aberrant gyrification affected all lobes in male PM carriers but occurred in higher frequencies in the temporal regions as compared with other cortical regions in female PM carriers (Fig. 2a). Seven male PM carriers and 5 female PM carriers showed hypergyrification in 1–6 regions (36.4%, Z = 2.58–5.33) while only one female control showed hypergyrification, and only in one region (3.6%, Z = 2.94). In addition, 9 male PM carriers and 8 female PM carriers showed hypogyrification in 1–17 regions (51.5%, Z = − 5.39 to − 2.58) while only two male controls and one female control showed hypogyrification, and in only one region per person (10.7%, Z = − 2.71 to − 2.59). Three of the 8 female PM carriers showed both hypogyrification (2–3 regions/person) and hypergyrification (1–2 regions/person). Figure 2b and c depicts the frequency of PM carriers with a specific number of aberrant regions. The group comparisons showed significantly higher percentages of hypergyrification regions, hypogyrification regions, and total aberrant gyrification regions in PM carriers than those of the controls (p < 0.0001–0.0008) (Table 3).

Figure 2
figure2

Hyper- and hypo-gyrification in individual PM carriers. (a) Number of male and female PM carriers showing hyper- and hypo-gyrification in the 34 cortical regions (left and right are combined). C, cingulate cortex; F, frontal lobe; O, occipital lobe; P, parietal lobe; T, temporal lobe. (b) Frequency of PM carriers with cortical regions showing hyper- versus hypo-gyrification. (c) Frequency of PM carriers with cortical regions showing either hyper- or hypo-gyrification. M, male PM carrier; F, female PM carrier.

Table 3 Comparisons of number of cortical regions with aberrant gyrification between carriers and controls.

We also observed that 9 male PM carriers and 2 female PM carriers had regions of aberrant LGI containing the primary sensorimotor cortices (i.e., precentral, postcentral, transverse temporal, and pericalcarine cortices) (primary group) while the remaining 7 male and 8 female PM carriers showed aberrant LGI only in the association cortices (association group). A comparison between the two groups revealed higher proportions of aberrant LGI regions in the primary group than the association group for PM boys [primary/associative: mean(SD) = 0.088(0.070)/0.019(0.007), range 0.029–0.25/0.015–0.029, t = 2.96, df = 8.20, p = 0.009] while the comparison did not show a significant difference in PM girls [primary/associative: mean(SD) = 0.147(0.022)/0.042(0.022), range 0.044–0.25/0.015–0.074, t = 1.013, df = 1.011, p = 0.247].

Cortical morphology correlated with cognitive performance

Cognitive assessment was performed using the Wechsler Intelligence Scale for Children, Fourth Edition (WISC-IV)37, which contains four subtests utilized in this study: namely, verbal comprehension index (VCI), perceptual reasoning index (PRI), working memory index (WMI), and processing speed index (PSI). Full scale IQ (FSIQ) of below 70 is traditionally used as a cutoff for intellectual disability. Only one PM boy had FSIQ of 51who was excluded from the analysis. The correlation of LGI, CT, and SA with WISC-IV scores was examined for the four groups separately using the whole-brain vertex-wise analysis. The WMI score (59) of a PM girl showing an outlier effect was also excluded. Setting both CFT and cluster-wise p value cutoffs at 0.010, significant LGI clusters peaked at the left and right precuneus showing positive correlations with PSI (cluster-wise p = 0.0002) and PRI (cluster-wise p = 0.0020), respectively, in male controls (Table 4, Fig. 3a,b). In addition, a cluster peaked at the right posterior cingulate cortex demonstrating significant positive correlations with PSI (cluster-wise p = 0.002) in PM boys (Fig. 3d) while a cluster peaked at the left caudal anterior cingulate showing a negative correlation with WMI (cluster-wise p = 0.0062) in PM girls (Fig. 3c). The only SA cluster that passed the thresholds peaked at the right rostral middle frontal cortex, showing a positive correlation with PSI in PM boys (cluster-wise p = 0.0080) while no significant CT clusters were detected in any of the four groups. After excluding the 4 scans acquired using a 32-channel head coil, only the two clusters of PM boys remained significant. The other three clusters were significant only at CFT of 0.05. After removing two 32-channel scans from the PM male group, a cluster centered at rostral middle frontal cortex passed the thresholds, revealing significant correlation between SA and VCI (Fig. 3f, Table 4). This cluster also passed the thresholds after adjusting for the Euler number while the PSI-SA cluster only approached significance (p = 0.029). All significant clusters also passed CFT of 0.005, showing cluster-wise p = 0.0002–0.0130 except the LGI-PRI cluster in male controls (Table 4).

Table 4 Correlation between cortical measurements and cognitive performance in controls and pm carriers.
Figure 3
figure3

Cortical regions showing significant correlations with cognitive performance. (a) The positive correlation between LGI and PSI in a cluster peaked at the right precuneus in male controls. (b) The positive correlation between LGI and PRI of a cluster peaked at the left precuneus in male controls. (c) The negative correlation between LGI and WMI in a cluster peaked at the left caudal anterior cingulate cortex in female PM carriers. (d) The positive correlation between LGI and PSI in a cluster peaked at right posterior cingulate cortex in male PM carriers. (e) The positive correlation between SA and PSI in a cluster peaked at the right rostral middle frontal cortex in 15 male PM carriers all scanned using an 8-channel headcoil. (f) The positive correlation between SA and VCI in a cluster peaked at the right rostral middle frontal cortex in 15 male PM carriers all scanned using an 8-channel headcoil. LGIs and SA adjusted for age and total cranial volume are shown. All clusters are formed using cluster-forming threshold of p = 0.010. Cluster-wise p values are shown in the graph.

Discussion

The current study compared cortical morphology among 8–12 year old children with the FMR1 normal and premutation alleles, and examined the correlations with FMR1 molecular measures and IQ subtest scores. To the best of our knowledge, this is the first neuroimaging study on children with the PM, which aimed to understand the neurobiological basis underlying cognitive development and psychiatric conditions that might occur in a subset of this population. We revealed a group-by-age interaction of LGI in the supramarginal and inferior parietal cortices (LGI1), a group-by-sex-by-age interaction of LGI in the right inferior temporal and fusiform cortices (LGI2), a group effect (PM vs. NC) of CT in the lateral and medial orbitofrontal and frontal pole cortices (CT1), and a group-by-sex-by-age interaction of CT in the right lateral occipital cortex (CT2) (Fig. 1, Table 2). Critically, the average LGI of the LGI2 cluster correlated significantly with CGG repeat length in both boys and girls with the PM, indicating the influence of the expanded CGG repeat length on the LGI change. We also applied a novel individualized method to identify individuals with aberrant gyrification, which detected a significantly higher percentage of brain regions with aberrant gyrification in the PM carriers compared with that in the controls (t = − 7.12, df = 56.7, p < 0.0001; Table 3). PM carriers with aberrant gyrification (78.8%) included 7 boys and 2 girls with hypergyrification in 1–6 cortical regions, 9 boys and 5 girls with hypogyrification in 1–17 regions, and 3 girls with both hyper- and hypo-gyrification in 3–5 regions (Fig. 2). Controls with aberrant gyrification (14.3%) included one girl with hypergyrification and two boys and one girl with hypogyrification in only one region per person. The LGI quantification also demonstrated functional significance by showing positive correlations with PRI and PSI in male controls and PM carriers, and a negative correlation with WMI in female PM carriers in the precuneus and cingulate regions (Fig. 3, Table 4).

The FMR1 gene is likely involved in cortical expansion and folding, the key processes in brain development that are evolutionally important and contribute to human intelligence38. Many early developmental processes can influence the tangential and radial growth of the cortical plate critical for gyrification, including the abundancies of progenitor cells, neurogenesis, gliogenesis, and basal radial glial cells as well as cell migration, dendritic arborization, formation of cortical connections, and modular progenitor cell density and gene expression differentiated according to regions destined to be gyri and sulci39,40,41. Mutation in genes involved in stem cell proliferation and differentiation and neuronal migration such as microtubule structural proteins (tubulin) or microtubule-associated proteins (MAPs) are associated with malformations of cortical development including lissencephaly, polymicrogyria, and periventricular nodular heterotopia42,43,44. FMRP expression starts from neurogenesis during early embryonic development in humans and is involved in neural stem cell differentiation, neuronal migration, and establishing balanced excitatory and inhibitory neuronal networks45,46,47. Loss of FMRP expression in fragile X syndrome (FXS) can lead to periventricular nodular heterotopia, the presence of nodules of gray matter along the lateral ventricles due to migration failure in some of the neurons during embryonic development44. Additional evidence supporting a potential link between FMR1 gene and aberrant gyrification include the FMRP regulation of microtubule network formation and transport of mitochondria in flies48, disoriented neuronal migration in embryonic knock-in mouse models of the FMR1 premutation26, and dysregulated global transcriptome in the second trimester of human PM fetuses using cell-free fetal RNA obtained from amniotic fluid supernatant49.

In this study, we provided corroborative findings, which demonstrated a high percentage (78.8%) of aberrant gyrification in PM children, characterized by variable presentation in the direction (i.e., hyper- and hypo-gyrification) and extent of affected cortical regions (1–17 regions/person) (Fig. 2b,c). Cortical regions at all levels of cortical hierarch were involved although the fusiform, inferior temporal, and medial temporal regions were more affected in PM girls than PM boys (Fig. 2a). In addition, PM boys with aberrant gyrification involving the primary sensorimotor cortices showed significantly higher proportions of aberrant LGI regions than those with aberrant LGI regions involving the associative cortices only (range 0.029–0.25 versus 0.015–0.029, p = 0.009). Since primary fissures formed early during cortical development may be under the highest genetic influence, while secondary and tertiary fissures formed later in the developmental processes50,51,52 are more influenced by environment and cortical plasticity52, both genes and environmental factors may contribute to aberrant gyrification observed across all cortical regions in the PM carriers. However, the molecular/cellular mechanisms of how PM can lead to both hyper- and hypo-gyrification are beyond the scope of current investigation and remain to be explored.

The high percentages of anxiety (80%), ADHD (50%), autistic symptoms (47.4% of the boys, 33.3% of the girls), and ID/borderline IQ (FSIQ < 80: 16.7% of the boys, 7.1% of the girls) in the PM group (Supplementary Table S1) was comparable to previous reports. However, these rates were not preferentially increased in probands in this cohort (Supplementary Table S2). In a study of 27 PM males (ages 4–22 years, 14 probands, 13 non-brobands), 93% of probands and 38% of non-probands met the criteria for ADHD while 79% of probands and 8% of non-probands had autistic symptoms9. In another study of 35 PM carriers (27 males, ages 5–23 years, 20 probands, 15 nonprobands), 70.6% were diagnosed with at least one anxiety disorder, and 33.3% males and 25% females had FSIQ < 808. Of the 3 boys and 1 girl with FSIQ < 80 in the current study, CGG repeat length was 147 (the larger allele for the girl), 152, 157, and 182, respectively, indicating the potential influence of low FMRP expression on IQ. The numbers of regions with aberrant gyrification were 3, 4, 6, and 17 regions, respectively. Gyrification has been studied in other developmental disorders including autism, anxiety, and ADHD, which showed inconsistent results regarding the direction of gyrification change and affected cortical regions. Hypergyrification in the temporal, parietal, and frontal regions has been reported in young adults with generalized anxiety disorder53 while hypogyrification in the similar frontoparietal to temporal regions has been reported in another study of young adults with panic disorder54. Hypogyrification in the frontal, temporal, and parietal regions has been reported in cross-sectional studies of children with ADHD55,56, but no group difference or age-related change were observed in a large longitudinal study of 234 children with ADHD compared with 231 typically developing children57. Both hyper- and hypo-gyrification in different cortical regions have been reported in children with autism quantified using Freesurfer58,59. These inconsistencies may indicate individual variability in gyrification within the patient populations and question the adequacy of group-specific analysis in identifying aberrant gyrification. The levels of CFT and cluster-selection threshold can also influence the results. In the current study, we applied multiple cutoff values considering different levels of potential false positives and false negatives (Tables 2 and 4).

In addition, LGI measures the degree of cortex buried within sulcal folds, which is influenced by sulcal depth and brain size in addition to sulcal frequency33,60. Consequently, unlike folding pattern that is mostly apparent at birth and remains stable throughout the adult life31,61, LGI declines with age in cross-sectional studies after adjusting for brain size, which is mainly attributable to cortical flattening starting from adolescence62,63,64. Therefore, findings of LGI change can reflect changes in sulcal depth in addition to folding degree. Methods of direct comparisons of folding degree such as sulcal pit and local spectral analysis have been proposed but currently, the methods are not publicly available64,65,66. Other methodology issues that we have encountered included insufficient sensitivity of Freesurfer in detecting tiny folds preferentially presented in the cingulate and pericalcarine cortices as well as more errors in the reconstructed white matter surface in brains with aberrant gyrification that required more manual intervention than brains with normal folding patterns. Topological complexity is reflected in the Euler number34,35, which makes it unsuitable to serve as a covariate for movement artifacts in LGI analyses. However, we have included the Euler number in the analyses of CT and SA, which has influenced most of the results. Since LGI, CT, and SA are highly correlated with each other revealed in our results and previous studies67, it remains elusive currently how to untangle the complex relationships between the Euler number, movement artifacts, and topological complexity and their effects on cortical measures. In addition, it is difficult to distinguish whether the MRI changes observed in this PM sample reflecting the PM status or neuropsychiatric conditions without a second non-carrier control group with a similar rate of anxiety or ADHD. The PM sample along with the findings in the current study likely represents a subgroup of PM children who have elevated risks for neuropsychiatric conditions. More studies on unbiased sample selections from the PM population are needed to establish a clear picture of clinical involvement and associated brain alterations.

In spite of these limitations, significant clusters centered in the supramarginal, lateral occipital, and orbitofrontal cortices revealed in the group analyses of LGI and CT (Fig. 1, Table 2) were consistent with findings from PM literatures. Deficient visual motion processing in infant and adult female PM carriers have been reported17 as well as reduced functional activities in the temporoparietal junction (containing the supramarginal region) during temporal processing68,69 and in the occipital region during emotional processing in adult PM carriers70. In addition, the orbitofrontal cortex along with the cingulate and prefrontal cortices showing significant correlation with WISC-IV subtest scores in PM carriers (Fig. 3) are part of the neural circuits implicated in ADHD71,72. These regions are also important for executive control function and response inhibition documented to show subtle impairment in adult PM carriers19,73. Further studies are needed to investigate whether gyrification quantification can serve as a useful biomarker of fetal/infant neurodevelopment associated with cognitive development and susceptibility for neurodevelopmental conditions experienced by some PM carriers.

Methods and materials

Participants

Both PM carriers and controls were recruited between 2008 and 2015 from families affected by FXS or were probands who were themselves seen in our clinic. Controls were also recruited from the local community through advertisements. Informed written consent was obtained from the caregiver of each participant. All aspects of the study were approved by the Institutional Review Board of the University of California, Davis and all methods were performed in accordance with their guidelines and regulations.

Participants with PM went through detailed medical examinations, and a history of developmental and medical problems was gathered for each. PM carrier status was confirmed by FMR1 DNA testing. CGG repeat size and methylation status were determined from genomic DNA isolated from peripheral blood lymphocytes using a combination of PCR and Southern blot analysis, as previously described74,75,76. Methylation status including percentage of methylation and for female PM carriers, the AR were measured by densitometry analysis76. Total RNA was isolated from 2.5 ml peripheral blood and FMR1 mRNA expression levels were measured by quantitative Real Time PCR using a 7900 Sequence detector (Applied Biosystems) as previously described27. All PM carriers included in this study carried only one single PM allele and did not show methylation on the FMR1 gene.

MRI acquisition and analysis

A Siemens Trio 3T MRI scanner (Siemens Medical Solutions, Erlangen, Germany) was used to collect T1-weighted magnetization-prepared rapid gradient-echo (MPRAGE) scans covering the whole brain. Across 8 years of image acquisition, two different acquisition protocols were utilized. See Table 5 for details. We used visual inspection as well as two quantitative methods to assess image quality. First, we obtained the Euler number, which was calculated based on total number of defect holes (g) on the reconstructed cortical surfaces prior to topological fixing provided by Freesurfer as 2–2g. The Euler number has been reported to correlate with manual identification of “unusable” scans and show complex relationships with cortical thickness35. However, the Euler number, reflecting topological complexity of reconstructed cortical surface, confounded with LGI. To compliment, we generated nine image QC metrics using the LONI Quality Control System36, including MSI, SNR, SVNR, CNR, CVNR, TCTV, FWHM, CoM, and COV. The LONI QC metrics have been validated against expert visual inspection for multi-site and multi-scanner structural MRI scans36. Two additional T1 scans acquired from a 7-year-old control male and a 13-year-old PM male not included in the study because of age and excessive motion were utilized as test scans.

Table 5 Acquisition protocols for MPRAGE.

For image preprocessing, the scans with the 0.475 mm3 image resolution were down-sampled to 1 mm3 using the mri_convert command from the Freesurfer software package34,77. All scans were then anterior–posterior commissure aligned automatically using the acpcdetect program from the Automated Registration Toolbox (www.nitrc.org/projects/art) followed by MRI bias field correction using N478. LGI quantifying cortical folding complexity at each vertex of reconstructed cerebral cortex was obtained using Freesurfer version 6.0 (https://surfer.nmr.mgh.harvard.edu/)33,34,77,79,80,81,82,83,84. Standard procedures for cortical reconstruction were carried out automatically including motion correction, brain extraction using a hybrid watershed/surface deformation, Talairach transformation, subcortical segmentation, intensity normalization, and tessellation of the gray and white matter boundary using a deformable surface algorithm to place the boundary at the location of greatest shift in intensity. Then deformable procedures were performed for surface inflation, registration to a spherical atlas based on individual cortical folding patterns, cortical parcellation, and generation of maps of surface-based measurement which included the thickness and surface area. After the Freesurfer process was completed, the gray and white matter boundaries were checked for accuracy and appropriate files were edited according to Freesurfer’s instruction followed by automatic regeneration of the gray and whiter matter surfaces. The last two steps were reiterated until all major errors were corrected. Finally, individual surface data was registered to Freesurfer template using Freesurfer’s spherical registration.

To compute LGI33, an outer smoothed surface tightly wrapping the pial surface was created and the gaps between gyri on the outer surface of the brain were closed. Then tessellation of the smoothed outer surface was performed, and the LGI at a given vertex was computed as the ratio between a spherical region on the outer surface centered at the vertex and the corresponding region on the pial surface, using the default diameter, 25 mm. Regional LGI data were also available for 68 cortical regions in the left and right hemispheres using the Desikan-Killiany atlas79,83.

Statistical analysis

Whole-brain vertex-wise comparisons of LGI, CT, and SA were performed to detect the effects of carrier-status, carrier-status-by-age, carrier-status-by-sex, and carrier-status-by-age-by-sex by using general linear models implemented in the mri_glmfit function of Freesurfer. As cranial size affects LGI, CT, and SA likewise60, Freesurfer-generated TCV was included as a covariate in all statistical models. Monte Carlo simulation was performed to correct multiple comparisons85. First, LGI was smoothed using FWHM Gaussian kernels of 5 mm consistent with previous studies of LGI86. Second, to balance the need for reducing both false positive rate and false negative rate, we examined CT and SA smoothed using 10 mm and 15 mm kernels given 10 mm as the most commonly used kernel and > 10 mm as the recommendation to reduce false positive rate87. Third, to reduce the data to sets of contiguous voxels with p values above a threshold85, three levels of CFT (0.05, 0.01, and 0.005) were tested and reported. The p value for cluster-wise correction for multiple comparisons was set to 0.05. The correlation between LGI and WISC-IV scores was examined similarly for each group excluding those with ID (FSIQ < 70, N = 1, a PM boy). Both the CFT and cluster-wise p value were set to 0.01. CFT of 0.005 was also tested for comparisons. Plots were inspected to identify potential outlier effect.

Individual participants with brain regions containing aberrant gyrification were identified using Z-scores relative to controls accounting for age, sex, and TCV. Individuals with Z-scores above 2.58 and below − 2.58 were considered as having hyper- and hypo-gyrification, respectively. Percentage of regions with hyper- and/or hypo-gyrification were compared between PM carriers and controls using t-tests. Correlations between quantitative measures were assessed using Pearson’s correlation coefficients. The analyses were conducted using the open-source statistical package R (https://www.r-project.org/).

References

  1. 1.

    Hagerman, P. J. & Hagerman, R. J. The fragile-X premutation: a maturing perspective. Am. J. Hum. Genet. 74, 805–816. https://doi.org/10.1086/386296 (2004).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  2. 2.

    Jacquemont, S. et al. Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population. JAMA 291, 460–469. https://doi.org/10.1001/jama.291.4.460 (2004).

    CAS  Article  PubMed  Google Scholar 

  3. 3.

    Rodriguez-Revenga, L. et al. Penetrance of FMR1 premutation associated pathologies in fragile X syndrome families. Eur. J. Hum. Genet. 17, 1359–1362. https://doi.org/10.1038/ejhg.2009.51 (2009).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  4. 4.

    Hagerman, R. J. et al. Fragile X-associated neuropsychiatric disorders (FXAND). Front. Psychiatry 9, 564. https://doi.org/10.3389/fpsyt.2018.00564 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  5. 5.

    Kraan, C. M. et al. FMR1 allele size distribution in 35,000 males and females: a comparison of developmental delay and general population cohorts. Genet. Med. 20, 1627–1634. https://doi.org/10.1038/gim.2018.52 (2018).

    Article  PubMed  Google Scholar 

  6. 6.

    Bailey, D. B. Jr., Raspa, M., Olmsted, M. & Holiday, D. B. Co-occurring conditions associated with FMR1 gene variations: findings from a national parent survey. Am. J. Med. Genet. A 146A, 2060–2069. https://doi.org/10.1002/ajmg.a.32439 (2008).

    CAS  Article  PubMed  Google Scholar 

  7. 7.

    Chonchaiya, W. et al. Increased prevalence of seizures in boys who were probands with the FMR1 premutation and co-morbid autism spectrum disorder. Hum. Genet. 131, 581–589. https://doi.org/10.1007/s00439-011-1106-6 (2012).

    Article  PubMed  Google Scholar 

  8. 8.

    Cordeiro, L., Abucayan, F., Hagerman, R., Tassone, F. & Hessl, D. Anxiety disorders in fragile X premutation carriers: preliminary characterization of probands and non-probands. Intractable Rare Dis. Res. 4, 123–130. https://doi.org/10.5582/irdr.2015.01029 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  9. 9.

    Farzin, F. et al. Autism spectrum disorders and attention-deficit/hyperactivity disorder in boys with the fragile X premutation. J. Dev. Behav. Pediatr. 27, S137-144. https://doi.org/10.1097/00004703-200604002-00012 (2006).

    Article  PubMed  Google Scholar 

  10. 10.

    Schneider, A. et al. Broad autism spectrum and obsessive-compulsive symptoms in adults with the fragile X premutation. Clin. Neuropsychol. 30, 929–943. https://doi.org/10.1080/13854046.2016.1189536 (2016).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  11. 11.

    Hessl, D. et al. Abnormal elevation of FMR1 mRNA is associated with psychological symptoms in individuals with the fragile X premutation. Am. J. Med. Genet. B Neuropsychiatr. Genet. 139B, 115–121. https://doi.org/10.1002/ajmg.b.30241 (2005).

    CAS  Article  PubMed  Google Scholar 

  12. 12.

    Roberts, J. E. et al. Mood and anxiety disorders in females with the FMR1 premutation. Am. J. Med. Genet. B Neuropsychiatr. Genet. 150B, 130–139. https://doi.org/10.1002/ajmg.b.30786 (2009).

    Article  PubMed  Google Scholar 

  13. 13.

    Bourgeois, J. A. et al. Lifetime prevalence of mood and anxiety disorders in fragile X premutation carriers. J. Clin. Psychiatry 72, 175–182. https://doi.org/10.4088/JCP.09m05407blu (2011).

    Article  PubMed  Google Scholar 

  14. 14.

    Gossett, A. et al. Psychiatric disorders among women with the fragile X premutation without children affected by fragile X syndrome. Am. J. Med. Genet. B Neuropsychiatr. Genet. 171, 1139–1147. https://doi.org/10.1002/ajmg.b.32496 (2016).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  15. 15.

    Wheeler, A. C. et al. Developmental profiles of infants with an FMR1 premutation. J. Neurodev. Disord. 8, 40. https://doi.org/10.1186/s11689-016-9171-8 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  16. 16.

    Raspa, M. et al. Sensory difficulties in children with an FMR1 premutation. Front. Genet. 9, 351. https://doi.org/10.3389/fgene.2018.00351 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  17. 17.

    Gallego, P. K., Burris, J. L. & Rivera, S. M. Visual motion processing deficits in infants with the fragile X premutation. J. Neurodev. Disord. 6, 29. https://doi.org/10.1186/1866-1955-6-29 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  18. 18.

    Shickman, R. et al. Age- and CGG repeat-related slowing of manual movement in fragile X carriers: a prodrome of fragile X-associated tremor ataxia syndrome?. Mov. Disord. 33, 628–636. https://doi.org/10.1002/mds.27314 (2018).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  19. 19.

    Grigsby, J. et al. Cognitive profile of fragile X premutation carriers with and without fragile X-associated tremor/ataxia syndrome. Neuropsychology 22, 48–60. https://doi.org/10.1037/0894-4105.22.1.48 (2008).

    Article  PubMed  Google Scholar 

  20. 20.

    Grigsby, J. et al. The cognitive neuropsychological phenotype of carriers of the FMR1 premutation. J. Neurodev. Disord. 6, 28. https://doi.org/10.1186/1866-1955-6-28 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  21. 21.

    Lozano, R. et al. Genomic studies in fragile X premutation carriers. J. Neurodev. Disord. 6, 27. https://doi.org/10.1186/1866-1955-6-27 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  22. 22.

    Napoli, E., Song, G., Wong, S., Hagerman, R. & Giulivi, C. Altered bioenergetics in primary dermal fibroblasts from adult carriers of the FMR1 premutation before the onset of the neurodegenerative disease fragile X-associated tremor/ataxia syndrome. Cerebellum 15, 552–564. https://doi.org/10.1007/s12311-016-0779-8 (2016).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  23. 23.

    Ross-Inta, C. et al. Evidence of mitochondrial dysfunction in fragile X-associated tremor/ataxia syndrome. Biochem. J. 429, 545–552. https://doi.org/10.1042/BJ20091960 (2010).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  24. 24.

    Hagerman, P. J. & Hagerman, R. J. Fragile X-associated tremor/ataxia syndrome. Ann. N. Y. Acad. Sci. 1338, 58–70. https://doi.org/10.1111/nyas.12693 (2015).

    ADS  CAS  Article  PubMed  PubMed Central  Google Scholar 

  25. 25.

    Todd, P. K. et al. CGG repeat-associated translation mediates neurodegeneration in fragile X tremor ataxia syndrome. Neuron 78, 440–455. https://doi.org/10.1016/j.neuron.2013.03.026 (2013).

    CAS  Article  PubMed  Google Scholar 

  26. 26.

    Cunningham, C. L. et al. Premutation CGG-repeat expansion of the Fmr1 gene impairs mouse neocortical development. Hum. Mol. Genet. 20, 64–79. https://doi.org/10.1093/hmg/ddq432 (2011).

    CAS  Article  PubMed  Google Scholar 

  27. 27.

    Tassone, F. et al. Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. Am. J. Hum. Genet. 66, 6–15. https://doi.org/10.1086/302720 (2000).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  28. 28.

    Sellier, C. et al. Sequestration of DROSHA and DGCR8 by expanded CGG RNA repeats alters microRNA processing in fragile X-associated tremor/ataxia syndrome. Cell Rep. 3, 869–880. https://doi.org/10.1016/j.celrep.2013.02.004 (2013).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  29. 29.

    Hagerman, R. & Hagerman, P. Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome. Lancet Neurol. 12, 786–798. https://doi.org/10.1016/S1474-4422(13)70125-X (2013).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  30. 30.

    Drozd, M. et al. Reduction of Fmr1 mRNA levels rescues pathological features in cortical neurons in a model of Fragile X associated Tremor Ataxia Syndrome. Mol. Ther. Nucleic Acid 18, 546–553 (2019).

    CAS  Article  Google Scholar 

  31. 31.

    Chi, J. G., Dooling, E. C. & Gilles, F. H. Gyral development of the human brain. Ann. Neurol. 1, 86–93. https://doi.org/10.1002/ana.410010109 (1977).

    CAS  Article  PubMed  Google Scholar 

  32. 32.

    Llinares-Benadero, C. & Borrell, V. Deconstructing cortical folding: genetic, cellular and mechanical determinants. Nat. Rev. Neurosci. https://doi.org/10.1038/s41583-018-0112-2 (2019).

    Article  PubMed  Google Scholar 

  33. 33.

    Schaer, M. et al. A surface-based approach to quantify local cortical gyrification. IEEE Trans. Med. Imaging 27, 161–170. https://doi.org/10.1109/TMI.2007.903576 (2008).

    Article  PubMed  Google Scholar 

  34. 34.

    Dale, A. M., Fischl, B. & Sereno, M. I. Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 9, 179–194. https://doi.org/10.1006/nimg.1998.0395 (1999).

    CAS  Article  PubMed  Google Scholar 

  35. 35.

    Rosen, A. F. G. et al. Quantitative assessment of structural image quality. Neuroimage 169, 407–418. https://doi.org/10.1016/j.neuroimage.2017.12.059 (2018).

    Article  PubMed  Google Scholar 

  36. 36.

    Kim, H. et al. The LONI QC system: a semi-automated, web-based and freely-available environment for the comprehensive quality control of neuroimaging data. Front. Neuroinform. 13, 60. https://doi.org/10.3389/fninf.2019.00060 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  37. 37.

    Wechsler, D. Wechsler Intelligence Scale for Children 4th edn. (The Psychological Corporation, New York, 2003).

    Google Scholar 

  38. 38.

    Garcia, K. E., Kroenke, C. D. & Bayly, P. V. Mechanics of cortical folding: stress, growth and stability. Philos. Trans. R. Soc. Lond. B Biol. Sci. 373, 1. https://doi.org/10.1098/rstb.2017.0321 (2018).

    Article  Google Scholar 

  39. 39.

    Sun, T. & Hevner, R. F. Growth and folding of the mammalian cerebral cortex: from molecules to malformations. Nat. Rev. Neurosci. 15, 217–232. https://doi.org/10.1038/nrn3707 (2014).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  40. 40.

    Kroenke, C. D. & Bayly, P. V. How forces fold the cerebral cortex. J. Neurosci. 38, 767–775. https://doi.org/10.1523/JNEUROSCI.1105-17.2017 (2018).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  41. 41.

    Xu, G. et al. Axons pull on the brain, but tension does not drive cortical folding. J. Biomech. Eng. 132, 071013. https://doi.org/10.1115/1.4001683 (2010).

    Article  PubMed  PubMed Central  Google Scholar 

  42. 42.

    Tan, A. P., Chong, W. K. & Mankad, K. Comprehensive genotype-phenotype correlation in lissencephaly. Quant. Imaging Med. Surg. 8, 673–693. https://doi.org/10.21037/qims.2018.08.08 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  43. 43.

    Stutterd, C. A. & Leventer, R. J. Polymicrogyria: a common and heterogeneous malformation of cortical development. Am. J. Med. Genet. C Semin. Med. Genet. 166C, 227–239. https://doi.org/10.1002/ajmg.c.31399 (2014).

    CAS  Article  PubMed  Google Scholar 

  44. 44.

    Parrini, E., Conti, V., Dobyns, W. B. & Guerrini, R. Genetic basis of brain malformations. Mol. Syndromol. 7, 220–233. https://doi.org/10.1159/000448639 (2016).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  45. 45.

    Abitbol, M. et al. Nucleus basalis magnocellularis and hippocampus are the major sites of FMR-1 expression in the human fetal brain. Nat. Genet. 4, 147–153. https://doi.org/10.1038/ng0693-147 (1993).

    CAS  Article  PubMed  Google Scholar 

  46. 46.

    Castren, M. et al. Altered differentiation of neural stem cells in fragile X syndrome. Proc. Natl. Acad. Sci. U.S.A. 102, 17834–17839. https://doi.org/10.1073/pnas.0508995102 (2005).

    ADS  CAS  Article  PubMed  PubMed Central  Google Scholar 

  47. 47.

    La Fata, G. et al. FMRP regulates multipolar to bipolar transition affecting neuronal migration and cortical circuitry. Nat. Neurosci. 17, 1693–1700. https://doi.org/10.1038/nn.3870 (2014).

    CAS  Article  PubMed  Google Scholar 

  48. 48.

    Yao, A. et al. Drosophila FMRP regulates microtubule network formation and axonal transport of mitochondria. Hum. Mol. Genet. 20, 51–63. https://doi.org/10.1093/hmg/ddq431 (2011).

    ADS  CAS  Article  PubMed  Google Scholar 

  49. 49.

    Zwemer, L. M. et al. Global transcriptome dysregulation in second trimester fetuses with FMR1 expansions. Prenat. Diagn. 37, 43–52. https://doi.org/10.1002/pd.4928 (2017).

    CAS  Article  PubMed  Google Scholar 

  50. 50.

    Lohmann, G., von Cramon, D. Y. & Steinmetz, H. Sulcal variability of twins. Cereb. Cortex 9, 754–763. https://doi.org/10.1093/cercor/9.7.754 (1999).

    CAS  Article  PubMed  Google Scholar 

  51. 51.

    White, T., Su, S., Schmidt, M., Kao, C. Y. & Sapiro, G. The development of gyrification in childhood and adolescence. Brain Cognit. 72, 36–45. https://doi.org/10.1016/j.bandc.2009.10.009 (2010).

    Article  Google Scholar 

  52. 52.

    Bartley, A. J., Jones, D. W. & Weinberger, D. R. Genetic variability of human brain size and cortical gyral patterns. Brain 120(Pt 2), 257–269. https://doi.org/10.1093/brain/120.2.257 (1997).

    Article  PubMed  Google Scholar 

  53. 53.

    Molent, C. et al. Reduced cortical thickness and increased gyrification in generalized anxiety disorder: a 3 T MRI study. Psychol. Med. 48, 2001–2010. https://doi.org/10.1017/S003329171700352X (2018).

    Article  PubMed  Google Scholar 

  54. 54.

    Yoon, S. et al. Altered cortical gyrification patterns in panic disorder: deficits and potential compensation. J. Psychiatr. Res. 47, 1446–1454. https://doi.org/10.1016/j.jpsychires.2013.06.015 (2013).

    Article  PubMed  Google Scholar 

  55. 55.

    Wolosin, S. M., Richardson, M. E., Hennessey, J. G., Denckla, M. B. & Mostofsky, S. H. Abnormal cerebral cortex structure in children with ADHD. Hum. Brain Mapp. 30, 175–184. https://doi.org/10.1002/hbm.20496 (2009).

    Article  PubMed  Google Scholar 

  56. 56.

    Mous, S. E. et al. Cortical morphology as a shared neurobiological substrate of attention-deficit/hyperactivity symptoms and executive functioning: a population-based pediatric neuroimaging study. J. Psychiatry Neurosci. 42, 103–112. https://doi.org/10.1503/jpn.150371 (2017).

    Article  PubMed  Google Scholar 

  57. 57.

    Shaw, P. et al. Development of cortical surface area and gyrification in attention-deficit/hyperactivity disorder. Biol. Psychiatry 72, 191–197. https://doi.org/10.1016/j.biopsych.2012.01.031 (2012).

    Article  PubMed  Google Scholar 

  58. 58.

    Schaer, M. et al. Decreased frontal gyrification correlates with altered connectivity in children with autism. Front. Hum. Neurosci. 7, 750. https://doi.org/10.3389/fnhum.2013.00750 (2013).

    Article  PubMed  PubMed Central  Google Scholar 

  59. 59.

    Yang, D. Y., Beam, D., Pelphrey, K. A., Abdullahi, S. & Jou, R. J. Cortical morphological markers in children with autism: a structural magnetic resonance imaging study of thickness, area, volume, and gyrification. Mol. Autism 7, 11. https://doi.org/10.1186/s13229-016-0076-x (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  60. 60.

    Toro, R. et al. Brain size and folding of the human cerebral cortex. Cereb. Cortex 18, 2352–2357. https://doi.org/10.1093/cercor/bhm261 (2008).

    Article  PubMed  Google Scholar 

  61. 61.

    Neil, J. J. & Smyser, C. D. Recent advances in the use of MRI to assess early human cortical development. J. Magn. Reson. 293, 56–69. https://doi.org/10.1016/j.jmr.2018.05.013 (2018).

    ADS  CAS  Article  PubMed  PubMed Central  Google Scholar 

  62. 62.

    Cao, B. et al. Lifespan gyrification trajectories of human brain in healthy individuals and patients with major psychiatric disorders. Sci. Rep. 7, 511. https://doi.org/10.1038/s41598-017-00582-1 (2017).

    ADS  CAS  Article  PubMed  PubMed Central  Google Scholar 

  63. 63.

    Hogstrom, L. J., Westlye, L. T., Walhovd, K. B. & Fjell, A. M. The structure of the cerebral cortex across adult life: age-related patterns of surface area, thickness, and gyrification. Cereb. Cortex 23, 2521–2530. https://doi.org/10.1093/cercor/bhs231 (2013).

    Article  PubMed  Google Scholar 

  64. 64.

    Aleman-Gomez, Y. et al. The human cerebral cortex flattens during adolescence. J. Neurosci. 33, 15004–15010. https://doi.org/10.1523/JNEUROSCI.1459-13.2013 (2013).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  65. 65.

    Im, K. et al. Reliable identification of deep sulcal pits: the effects of scan session, scanner, and surface extraction tool. PLoS ONE 8, e53678. https://doi.org/10.1371/journal.pone.0053678 (2013).

    ADS  CAS  Article  PubMed  PubMed Central  Google Scholar 

  66. 66.

    Rabiei, H., Richard, F., Coulon, O. & Lefevre, J. Local spectral analysis of the cerebral cortex: new gyrification indices. IEEE Trans. Med. Imaging 36, 838–848. https://doi.org/10.1109/TMI.2016.2633393 (2017).

    Article  PubMed  Google Scholar 

  67. 67.

    Forde, N. J. et al. Healthy cortical development through adolescence and early adulthood. Brain Struct. Funct. 222, 3653–3663. https://doi.org/10.1007/s00429-017-1424-0 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  68. 68.

    Kim, S. Y., Tassone, F., Simon, T. J. & Rivera, S. M. Altered neural activity in the “when” pathway during temporal processing in fragile X premutation carriers. Behav. Brain Res. 261, 240–248. https://doi.org/10.1016/j.bbr.2013.12.044 (2014).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  69. 69.

    Keri, S. & Benedek, G. The perception of biological and mechanical motion in female fragile X premutation carriers. Brain Cognit. 72, 197–201. https://doi.org/10.1016/j.bandc.2009.08.010 (2010).

    Article  Google Scholar 

  70. 70.

    Brown, S. S. G., Whalley, H. C., Kind, P. C. & Stanfield, A. C. Decreased functional brain response to emotional arousal and increased psychiatric symptomology in FMR1 premutation carriers. Psychiatry Res. Neuroimaging 285, 9–17. https://doi.org/10.1016/j.pscychresns.2019.01.011 (2019).

    Article  PubMed  Google Scholar 

  71. 71.

    Gallo, E. F. & Posner, J. Moving towards causality in attention-deficit hyperactivity disorder: overview of neural and genetic mechanisms. Lancet Psychiatry 3, 555–567. https://doi.org/10.1016/S2215-0366(16)00096-1 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  72. 72.

    Bayard, F. et al. Distinct brain structure and behavior related to ADHD and conduct disorder traits. Mol. Psychiatry https://doi.org/10.1038/s41380-018-0202-6 (2018).

    Article  PubMed  Google Scholar 

  73. 73.

    Kraan, C. M. et al. Impaired response inhibition is associated with self-reported symptoms of depression, anxiety, and ADHD in female FMR1 premutation carriers. Am. J. Med. Genet. B Neuropsychiatr. Genet. 165B, 41–51. https://doi.org/10.1002/ajmg.b.32203 (2014).

    CAS  Article  PubMed  Google Scholar 

  74. 74.

    Filipovic-Sadic, S. et al. A novel FMR1 PCR method for the routine detection of low abundance expanded alleles and full mutations in fragile X syndrome. Clin. Chem. 56, 399–408. https://doi.org/10.1373/clinchem.2009.136101 (2010).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  75. 75.

    Tassone, F., Pan, R., Amiri, K., Taylor, A. K. & Hagerman, P. J. A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations. J. Mol. Diagn. 10, 43–49. https://doi.org/10.2353/jmoldx.2008.070073 (2008).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  76. 76.

    Tassone, F. et al. FMRP expression as a potential prognostic indicator in fragile X syndrome. Am. J. Med. Genet. 84, 250–261 (1999).

    CAS  Article  Google Scholar 

  77. 77.

    Fischl, B., Sereno, M. I. & Dale, A. M. Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system. Neuroimage 9, 195–207. https://doi.org/10.1006/nimg.1998.0396 (1999).

    CAS  Article  PubMed  Google Scholar 

  78. 78.

    Tustison, N. J. et al. N4ITK: improved N3 bias correction. IEEE Trans. Med. Imaging 29, 1310–1320. https://doi.org/10.1109/TMI.2010.2046908 (2010).

    Article  PubMed  PubMed Central  Google Scholar 

  79. 79.

    Desikan, R. S. et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 31, 968–980. https://doi.org/10.1016/j.neuroimage.2006.01.021 (2006).

    Article  PubMed  Google Scholar 

  80. 80.

    Fischl, B. & Dale, A. M. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc. Natl. Acad. Sci. U.S.A. 97, 11050–11055. https://doi.org/10.1073/pnas.200033797 (2000).

    ADS  CAS  Article  PubMed  PubMed Central  Google Scholar 

  81. 81.

    Fischl, B. et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 33, 341–355. https://doi.org/10.1016/S0896-6273(02)00569-X (2002).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  82. 82.

    Fischl, B., Sereno, M. I., Tootell, R. B. & Dale, A. M. High-resolution intersubject averaging and a coordinate system for the cortical surface. Hum. Brain Mapp. 8, 272–284. https://doi.org/10.1002/(SICI)1097-0193(1999)8:4%3c272::AID-HBM10%3e3.0.CO;2-4 (1999).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  83. 83.

    Fischl, B. et al. Automatically parcellating the human cerebral cortex. Cereb. Cortex 14, 11–22 (2004).

    Article  Google Scholar 

  84. 84.

    Segonne, F. et al. A hybrid approach to the skull stripping problem in MRI. Neuroimage 22, 1060–1075. https://doi.org/10.1016/j.neuroimage.2004.03.032 (2004).

    CAS  Article  PubMed  Google Scholar 

  85. 85.

    Hagler, D. J. Jr., Saygin, A. P. & Sereno, M. I. Smoothing and cluster thresholding for cortical surface-based group analysis of fMRI data. Neuroimage 33, 1093–1103. https://doi.org/10.1016/j.neuroimage.2006.07.036 (2006).

    Article  PubMed  PubMed Central  Google Scholar 

  86. 86.

    Blanken, L. M. et al. Cortical morphology in 6- to 10-year old children with autistic traits: a population-based neuroimaging study. Am. J. Psychiatry 172, 479–486. https://doi.org/10.1176/appi.ajp.2014.14040482 (2015).

    Article  PubMed  Google Scholar 

  87. 87.

    Greve, D. N. & Fischl, B. False positive rates in surface-based anatomical analysis. Neuroimage 171, 6–14. https://doi.org/10.1016/j.neuroimage.2017.12.072 (2018).

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We are grateful to the research participants and their families; to Patrick Adams and Yingratana McLennan for data collection. This project was supported by NIH Roadmap Grant DE019583, NIH Grant HD036071 to R.J.H., the MIND Institute IDDRC Grant U54 HD079125, and private donors.

Author information

Affiliations

Authors

Contributions

Dr. J.Y.W. designed the study. Dr. J.Y.W., Ms. M.D., Mr. C.S., Ms. B.Kim, and Ms. Y.X. generated the MRI measurements. Dr. J.Y.W. and Ms. M.D. performed the statistical analyses and drafted the manuscript. Dr. K.K. supervised the statistical analyses. Dr. F.T. provided molecular data. Dr. J.Y.W. revised the manuscript. All authors critically reviewed the manuscript. Dr. R.J.H. and Dr. S.M.R. obtained clinical data and MRI scans, provided financial and instrumental support, and supervised the study.

Corresponding author

Correspondence to Jun Yi Wang.

Ethics declarations

Competing interests

Dr. Hagerman has received funding from Zynerba, Ovid, and the Azrieli Foundation for treatment studies in fragile X syndrome (FXS). She has also consulted with Zynerba, Ovid, and Fulcrum regarding treatment studies in FXS. Dr. Tassone has received funding from Asuragen and Zynerba for studies in FXS. The funders had no role in study design, data collection, analysis, data interpretation, or manuscript writing. All other authors report no biomedical financial interests or potential conflicts of interest.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Wang, J.Y., Danial, M., Soleymanzadeh, C. et al. Cortical gyrification and its relationships with molecular measures and cognition in children with the FMR1 premutation. Sci Rep 10, 16059 (2020). https://doi.org/10.1038/s41598-020-73040-0

Download citation

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing